Search Results

There are 14464 results for: content related to: Molecular requirements for safer generation of thrombolytics by bioengineering the tissue-type plasminogen activator A chain

  1. You have free access to this content
    Engineering of plasminogen activators for targeting to thrombus and heightening thrombolytic efficacy

    Journal of Thrombosis and Haemostasis

    Volume 13, Issue 9, September 2015, Pages: 1545–1556, S. Absar, N. Gupta, K. Nahar and F. Ahsan

    Version of Record online : 27 JUL 2015, DOI: 10.1111/jth.13033

  2. You have free access to this content
    Viscoelastic measurements of platelet function, not fibrinogen function, predicts sensitivity to tissue-type plasminogen activator in trauma patients

    Journal of Thrombosis and Haemostasis

    Volume 13, Issue 10, October 2015, Pages: 1878–1887, H. B. Moore, E. E. Moore, M. P. Chapman, E. Gonzalez, A. L. Slaughter, A. P. Morton, A. D'Alessandro, K. C. Hansen, A. Sauaia, A. Banerjee and C. C. Silliman

    Version of Record online : 22 SEP 2015, DOI: 10.1111/jth.13067

  3. You have free access to this content
    Endogenous t-PA-antigen is an independent predictor of adverse cardiovascular events and all-cause death in patients with atrial fibrillation

    Journal of Thrombosis and Haemostasis

    Volume 11, Issue 6, June 2013, Pages: 1069–1077, M. K. Freynhofer, D. F. Draxler, S. C. Gruber, V. Bruno, T. Höchtl, B. Fellner, G. Jakl-Kotauschek, J. Wojta, I. Pabinger-Fasching, K. Huber and C. Ay

    Version of Record online : 3 JUL 2013, DOI: 10.1111/jth.12213

  4. Valproic acid selectively increases vascular endothelial tissue-type plasminogen activator production and reduces thrombus formation in the mouse

    Journal of Thrombosis and Haemostasis

    Volume 14, Issue 12, December 2016, Pages: 2496–2508, P. Larsson, I. Alwis, B. Niego, M. Sashindranath, P. Fogelstrand, M. C. L. Wu, L. Glise, M. Magnusson, M. Daglas, N. Bergh, S. P. Jackson, R. L. Medcalf and S. Jern

    Version of Record online : 23 NOV 2016, DOI: 10.1111/jth.13527

  5. You have free access to this content
    Molecular mechanisms of the effect of ultrasound on the fibrinolysis of clots

    Journal of Thrombosis and Haemostasis

    Volume 13, Issue 4, April 2015, Pages: 601–609, I. N. Chernysh, C. E. Everbach, P. K. Purohit and J. W. Weisel

    Version of Record online : 13 MAR 2015, DOI: 10.1111/jth.12857

  6. You have free access to this content
    Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management

    Journal of Thrombosis and Haemostasis

    Volume 13, Issue 6, June 2015, Pages: 909–919, A. Casini, M. Neerman-Arbez, R. A. Ariëns and P. de Moerloose

    Version of Record online : 2 MAY 2015, DOI: 10.1111/jth.12916

  7. A quantitative systems pharmacology model of blood coagulation network describes in vivo biomarker changes in non-bleeding subjects

    Journal of Thrombosis and Haemostasis

    Volume 14, Issue 12, December 2016, Pages: 2430–2445, D. Lee, S. Nayak, S. W. Martin, A. C. Heatherington, P. Vicini and F. Hua

    Version of Record online : 27 DEC 2016, DOI: 10.1111/jth.13515

  8. Fibrinolysis inhibitors in plaque stability: a morphological association of PAI-1 and TAFI in advanced carotid plaque

    Journal of Thrombosis and Haemostasis

    Volume 15, Issue 4, April 2017, Pages: 758–769, A.-C. Jönsson Rylander, A. Lindgren, J. Deinum, G. M. L. Bergström, G. Böttcher, I. Kalies and K. Wåhlander

    Version of Record online : 28 FEB 2017, DOI: 10.1111/jth.13641

  9. You have free access to this content
    Treatment of acute ischemic stroke: from fibrinolysis to neurointervention

    Journal of Thrombosis and Haemostasis

    Volume 13, Issue S1, June 2015, Pages: S290–S296, G. J. Jacquin and B. A. van Adel

    Version of Record online : 19 JUN 2015, DOI: 10.1111/jth.12971

  10. You have full text access to this OnlineOpen article
    Compaction of fibrin clots reveals the antifibrinolytic effect of factor XIII

    Journal of Thrombosis and Haemostasis

    Volume 14, Issue 7, July 2016, Pages: 1453–1461, D. C. Rijken, S. Abdul, J. J. M. C. Malfliet, F. W. G. Leebeek and S. Uitte de Willige

    Version of Record online : 9 JUN 2016, DOI: 10.1111/jth.13354

  11. You have free access to this content
    Effect of warfarin treatment on thrombin activatable fibrinolysis inhibitor (TAFI) activation and TAFI-mediated inhibition of fibrinolysis

    Journal of Thrombosis and Haemostasis

    Volume 11, Issue 2, February 2013, Pages: 315–324, F. Incampo, C. Carrieri, R. Galasso, F. A. Scaraggi, F. Di Serio, B. Woodhams, N. Semeraro and M. Colucci

    Version of Record online : 7 FEB 2013, DOI: 10.1111/jth.12102

  12. You have free access to this content
    Interleukin-33 induces urokinase in human endothelial cells―possible impact on angiogenesis

    Journal of Thrombosis and Haemostasis

    Volume 12, Issue 6, June 2014, Pages: 948–957, S. Stojkovic, C. Kaun, M. Heinz, K. A. Krychtiuk, S. Rauscher, C. E. Lemberger, R. de Martin, M. Gröger, P. Petzelbauer, I. Huk, K. Huber, J. Wojta and S. Demyanets

    Version of Record online : 10 JUN 2014, DOI: 10.1111/jth.12581

  13. You have free access to this content
    Monoclonal antibodies targeting the antifibrinolytic activity of activated thrombin-activatable fibrinolysis inhibitor but not the anti-inflammatory activity on osteopontin and C5a

    Journal of Thrombosis and Haemostasis

    Volume 11, Issue 12, December 2013, Pages: 2137–2147, F. Semeraro, C. T. Ammollo, A. Gils, P. J. Declerck and M. Colucci

    Version of Record online : 10 DEC 2013, DOI: 10.1111/jth.12431

  14. A first-in-human study of DS-1040, an inhibitor of the activated form of thrombin-activatable fibrinolysis inhibitor, in healthy subjects

    Journal of Thrombosis and Haemostasis

    Volume 15, Issue 5, May 2017, Pages: 961–971, J. Zhou, J. Kochan, O. Yin, V. Warren, C. Zamora, G. Atiee, J. Pav, Y. Orihashi, V. Vashi and V. Dishy

    Version of Record online : 11 MAR 2017, DOI: 10.1111/jth.13658

  15. You have full text access to this OnlineOpen article
    Conformational quiescence of ADAMTS-13 prevents proteolytic promiscuity

    Journal of Thrombosis and Haemostasis

    Volume 14, Issue 10, October 2016, Pages: 2011–2022, K. South, M. O. Freitas and D. A Lane

    Version of Record online : 23 SEP 2016, DOI: 10.1111/jth.13445

  16. Reduced fibrinolytic resistance in patients with factor XI deficiency. Evidence of a thrombin-independent impairment of the thrombin-activatable fibrinolysis inhibitor pathway

    Journal of Thrombosis and Haemostasis

    Volume 14, Issue 8, August 2016, Pages: 1603–1614, M. Colucci, F. Incampo, A. Cannavò, M. Menegatti, S. M. Siboni, F. Zaccaria, N. Semeraro and F. Peyvandi

    Version of Record online : 18 JUL 2016, DOI: 10.1111/jth.13342

  17. You have free access to this content
    Coagulopathy and its management in patients with severe burns

    Journal of Thrombosis and Haemostasis

    Volume 14, Issue 5, May 2016, Pages: 865–874, G. J. Glas, M. Levi and M. J. Schultz

    Version of Record online : 23 MAR 2016, DOI: 10.1111/jth.13283

  18. You have free access to this content
    FXIII: mechanisms of action in the treatment of hemophilia A

    Journal of Thrombosis and Haemostasis

    Volume 12, Issue 2, February 2014, Pages: 159–168, C. J. Rea, J. H. Foley, O. Okaisabor and B. Sørensen

    Version of Record online : 7 FEB 2014, DOI: 10.1111/jth.12478

  19. α1-antitrypsin Pittsburgh and plasmin-mediated proteolysis

    Journal of Thrombosis and Haemostasis

    Volume 14, Issue 10, October 2016, Pages: 2023–2026, A. Henneuse, P. Suchon, H. Chambost, P. E. Morange, C. Frere and M. C. Alessi

    Version of Record online : 2 SEP 2016, DOI: 10.1111/jth.13426

  20. You have free access to this content
    Fibrinolytic and procoagulant activities of Yersinia pestis and Salmonella enterica

    Journal of Thrombosis and Haemostasis

    Volume 13, Issue S1, June 2015, Pages: S115–S120, T. K. Korhonen

    Version of Record online : 19 JUN 2015, DOI: 10.1111/jth.12932